Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies
Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Recruiting

Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS

NCT06126315

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Concord Hospital Sydney, Australia
  • Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Dipartimento di Neurologia Bergamo, Italy
  • Fondazione Serena ONLUS Centro Clinico NEMO Brescia Brescia, Italy
  • Istituto Auxologico Italiano, IRCCS Dipartimento di Neurologia Milan, Italy
View all 19 locations
View Trial Details
Recruiting

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

NCT03127267

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • University of Kentucky Lexington, Kentucky, United States
  • Johns Hopkins Medicine Brain Science Institute Baltimore, Maryland, United States
View all 56 locations
View Trial Details

Related conditions